Brief: Ocumension Therapeutics Sees Total Rev Of About RMB155.0 Mln To RMB159.0 Mln For Year

Ocumension Therapeutics

14/02/2023 24:35

Feb 14 (Reuters) - Ocumension Therapeutics  1477.HK :
    * SEES TOTAL REVENUE OF ABOUT RMB155.0 MILLION TO RMB159.0
MILLION
FOR YEAR
    * SEES A GROSS PROFIT OF APPROXIMATELY RMB100.0 MILLION TO
RMB103.0 MILLION FOR YEAR
    * EXPECTED RESULT DUE TO COMMERCIALIZATION OF CO'S CORE
PRODUCT,
AMONG OTHERS

Source text for Eikon:  ID: 
Further company coverage:  1477.HK 
 ((Reuters.Briefs@thomsonreuters.com;))